Psychiatric Times

10/21/2026

🎃 The entire October issue of Psychiatric Times is now live on our website. Read it here: https://www.psychiatrictimes.com/journals/psychiatric-times/vol-43-issue-10

10/21/2026

In our latest CME article, learn how to recognize historical and persistent barriers to the ethical use of long-acting injectable antipsychotics.

Explore evolving ethical challenges of long-acting injectable antipsychotics, weighing relapse prevention against coercion, stigma, incentives, and racial equity in clinical practice.

10/20/2026

Many adults with ADHD go undiagnosed for years, partly because their symptoms don't match what we expect from kids. In our new Peer Exchange, Carolyn Lentzsch-Parcells, MD, Maitri Patel, MD, and Michael Feld, MD, explain what adult ADHD really looks like, how to diagnose it, and why catching it early matters. Watch here:

Managing Adult ADHD: Addressing Diagnosis, Treatment Selection, and All-Day Symptom Control | Peer Exchange | Psychiatric Times is the connection to Psychiatry and Mental Health, featuring clinical updates, expert views, and research news in multimedia formats.

10/20/2026

According to a new review, ADHD medications may help improve brain fog in perimenopausal women.

Review finds ADHD drugs may ease perimenopause brain fog and improve daily focus, but objective cognition gains remain unclear; larger safety and efficacy studies needed.

10/19/2026

🎙️ Episode 2 of The Psych Consult: Second Opinion is here!

Claire Brandon, MD, and endocrinologist Caroline Messer, MD, discuss where thyroid disease and psychiatric illness overlap.

🔗

An endocrinologist warns psychiatrists against overreading peripheral thyroid hormones and flags kelp and T3 microdosing as underrecognized risks.

10/19/2026

🦠 Phase 2 signal-finding trial of bezisterim for the treatment of long COVID shows safety and symptom gains, with strongest benefits for severe fatigue, post-exertional malaise, and cognitive issues.

Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.

10/17/2026

Rethink approaches to schizophrenia management.

Join our live national broadcast to hear an expert panel examine evidence for current and emerging therapeutic approaches and practical strategies for integrating novel therapies into clinical practice. The discussion will also address managing side effects, supporting treatment persistence, and optimizing long-term functional outcomes. bit.ly/4yjLpCB

10/15/2026

🏃 Athletes can feel the relief a substance gives them long before they can see what it costs.

Check out this composite case of cannabis use in a track athlete to learn more about how to assess.

Athletes can feel the relief a substance gives them long before they can see what it costs. A composite case of cannabis use in a track athlete shows how to assess both.

10/14/2026

A psychiatric nurse practitioner shares mentorship lessons, training fixes, and practical tips to close prescriber gaps and improve team-based care in this week's episode of "Psyched Perspectives."

A psychiatric NP shares mentorship lessons, training fixes, and her Psych NP Boot Camp—plus practical tips to close prescriber gaps and improve team-based care.

10/14/2026

Today marks the first-ever Treatment-Resistant Depression Awareness Day in the US.

First US TRD Awareness Day spotlights treatment-resistant depression, urging earlier recognition, stigma-breaking support, and renewed hope for patients and caregivers.